Citations (92)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Xiao Yu, H Karl Greenblatt & David J Greenblatt. (2023) Designer benzodiazepines: an update. Expert Review of Clinical Pharmacology 16:2, pages 109-117.
Read now
Read now
Samima Khatun, Abhinav Singh, Ghulam N. Bader & Firdoos Ahmad Sofi. (2022) Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances. Journal of Biomolecular Structure and Dynamics 40:24, pages 14279-14302.
Read now
Read now
Ayami Kajiwara, Masato Yamamura, Motoji Murase, Haruo Koda, Seisuke Hirota, Tadao Ishizuka, Kazunori Morita, Kentaro Oniki, Junji Saruwatari & Kazuko Nakagawa. (2016) Safety analysis of zolpidem in elderly subjects 80 years of age or older: adverse event monitoring in Japanese subjects. Aging & Mental Health 20:6, pages 611-615.
Read now
Read now
Hedva B Levy. (2014) Non-benzodiazepine hypnotics and older adults: what are we learning about zolpidem?. Expert Review of Clinical Pharmacology 7:1, pages 5-8.
Read now
Read now
David J Greenblatt & Gary K Zammit. (2012) Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications. Expert Opinion on Drug Metabolism & Toxicology 8:12, pages 1609-1618.
Read now
Read now
Articles from other publishers (87)
Carlotta Mutti, Giulia Malagutti, Valentina Maraglino, Francesco Misirocchi, Alessandro Zilioli, Francesco Rausa, Silvia Pizzarotti, Marco Spallazzi, Ivana Rosenzweig & Liborio Parrino. (2023) Sleep Pathologies and Eating Disorders: A Crossroad for Neurology, Psychiatry and Nutrition. Nutrients 15:20, pages 4488.
Crossref
Crossref
Luciano Ferreira Drager, Márcia Assis, Andrea Frota Rego Bacelar, Dalva Lucia Rollemberg Poyares, Silvia Gonçalves Conway, Gabriel Natan Pires, Alexandre Pinto de Azevedo, Alicia Carissimi, Allan Luiz Eckeli, Álvaro Pentagna, Carlos Maurício Oliveira Almeida, Clélia Maria Ribeiro Franco, Emmanuelle Silva Tavares Sobreira, Fernando Gustavo Stelzer, Giuliana Macedo Mendes, Gisele Richter Minhoto, Ila Marques Porto Linares, Ksdy Maiara Moura Sousa, Livia Leite Góes Gitaí, Lucia Sukys-Claudino, Manoel Alves Sobreira-Neto, Marcio Andrei Zanini, Regina Margis & Sandra Cristina Gonçalves Martinez. (2023) 2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults – Brazilian Sleep Association. Sleep Science 16:S 02.
Crossref
Crossref
Helen Zhao, Marina DiMarco, Kelsey Ichikawa, Marion Boulicault, Meg Perret, Kai Jillson, Alexandra Fair, Kai DeJesus & Sarah S. Richardson. (2023) Making a ‘sex-difference fact’: Ambien dosing at the interface of policy, regulation, women’s health, and biology. Social Studies of Science 53:4, pages 475-494.
Crossref
Crossref
Hiba Khan, Aakriti Garg, Yasmeen, Nidhi B. Agarwal, Deepak Kumar Yadav, Mohd. Ashif Khan & Salman Hussain. (2022) Zolpidem use and risk of suicide: A systematic review and meta-analysis. Psychiatry Research 316, pages 114777.
Crossref
Crossref
Lamya Ahmed Al-Keridis, Fahd Mohammed Abd Al Galil, Fahd A Al-Mekhlafi, Muhammad A Wadaan & Mohammed S Al-Khalifa. (2022)
Impact of Hypnotic Drug Zolpidem Tartrate on the Development of Forensic Fly
Sarcophaga ruficornis
(Diptera: Sarcophagidae)
. Journal of Medical Entomology 59:3, pages 820-825.
Crossref
Crossref
Sungeun Hwang, Hyoshin Son, Manho Kim, Sang Kun Lee & Ki-Young Jung. (2022) Association of Zolpidem With Increased Mortality in Patients With Brain Cancer: A Retrospective Cohort Study Based on the National Health Insurance Service Database. Journal of Clinical Neurology 18:1, pages 65.
Crossref
Crossref
O.V. Kotova, E.V. Tsareva, V.E. Medvedev, A.A. Belyaev, E.V. Gushanskaya, V.I. Frolova & I.G. Kotelnikova. (2022) Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:12, pages 39.
Crossref
Crossref
Luciana L. Louzada, Flávio V. Machado, Juliana L. Quintas, Guilherme A. Ribeiro, Mônica V. Silva, Dayde L. Mendonça-Silva, Bruno S. B. Gonçalves, Otávio T. Nóbrega & Einstein F. Camargos. (2021) The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer’s disease: a randomized, triple-blind, placebo-controlled trial. Neuropsychopharmacology 47:2, pages 570-579.
Crossref
Crossref
Michael Soyka. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
494
509
.
Thomas Dahl, Gary Zammit, Maha Ahmad, Russell Rosenberg, Lan Bo Chen & Thomas Roth. (2021) Efficacy of the triple-combination SM-1 in a 5-h phase advance transient insomnia model. Sleep and Biological Rhythms 20:1, pages 47-52.
Crossref
Crossref
Ting Xiang, Yixian Cai, Zhijin Hong & Jiyang Pan. (2021) Efficacy and safety of Zolpidem in the treatment of insomnia disorder for one month: a meta-analysis of a randomized controlled trial. Sleep Medicine 87, pages 250-256.
Crossref
Crossref
Michael Soyka. (2021) Missbrauch und Abhängigkeit von Benzodiazepinen und Z-Drugs. Nervenheilkunde 40:08, pages 636-647.
Crossref
Crossref
Jinbo Huang, Dandan Wu, Xiaokang Bai, Panyuan Cai & Wei-Guo Zhu. (2021)
Catalyst-free, visible-light-induced direct radical cross-coupling perfluoroalkylation of the imidazo[1,2-
a
]pyridines with perfluoroalkyl iodides
. New Journal of Chemistry 45:11, pages 4925-4929.
Crossref
Crossref
Domenico De Donatis, Stefano Porcelli, Alessandro Serretti, Davide Gaspari, Saverio Simone Caltagirone, Giancarlo Giupponi, Maurizio Ferraro, Andreas Conca, Vincenzo Florio, Gerald Zernig & Laura Mercolini. (2021) Extremely High-Dosage Zolpidem Poisoning With Favorable Outcome. Journal of Clinical Psychopharmacology 41:2, pages 222-223.
Crossref
Crossref
Junsik Lim, Kanghyun Leem & Taeyeon Kim. (2021) Sleep-promoting and Anti-anxiety Effects of Shihogayonggolmoryo-tang in Mice. Journal of Physiology & Pathology in Korean Medicine 35:1, pages 8-14.
Crossref
Crossref
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide
871
874
.
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide.
Eui Hyun Jung, Choong-Min Lee, Ji-Yeong Byeon, Hyo-Bin Shin, Kyung-Yul Oh, Chang-Keun Cho, Chang Woo Lim, Choon-Gon Jang, Seok-Yong Lee & Yun Jeong Lee. (2020) Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects. Archives of Pharmacal Research 43:9, pages 976-981.
Crossref
Crossref
Flávio V. Machado, Luciana L. Louzada, Nathan E. Cross, Einstein F. Camargos, Thien Thanh Dang-Vu & Otávio T. Nóbrega. (2020) More than a quarter century of the most prescribed sleeping pill: Systematic review of zolpidem use by older adults. Experimental Gerontology 136, pages 110962.
Crossref
Crossref
Dongamanti Ashok, M. Ram Reddy, Katta Ramakrishna, Nalaparaju Nagaraju, Ravinder Dharavath & Madderla Sarasija. (2020) Iodine mediated synthesis of some new imidazo[1,2‐a]pyridine derivatives and evaluation of their antimicrobial activity. Journal of Heterocyclic Chemistry 57:6, pages 2528-2534.
Crossref
Crossref
Laura S. Castro, Leonardo J. Otuyama, Cristiane Fumo-dos-Santos, Sergio Tufik & Dalva Poyares. (2020) Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial. Brazilian Journal of Psychiatry 42:2, pages 175-184.
Crossref
Crossref
Gustavo D. Mendes, Thais da Silva Pereira, Júlio César Rodrigues, Elaine Marcílio Santos, Mariani Rafaela Souza, Rodrigo Alvaro Brandão Lopes‐Martins, Natalícia de Jesus Antunes, Ronilson Agnaldo Moreno & Gilberto De Nucci. (2020) Comparative bioavailability of two zolpidem hemitartrate formulations in healthy human Brazilian volunteers using high‐performance liquid chromatography coupled to tandem mass spectrometry. Biomedical Chromatography 34:4.
Crossref
Crossref
Chul-Hyun Cho, Hee-Jung Jee, Yoon-Ju Nam, Hyonggin An, Leen Kim & Heon-Jeong Lee. (2020) Temporal association between zolpidem medication and the risk of suicide: A 12-year population-based, retrospective cohort study. Scientific Reports 10:1.
Crossref
Crossref
Thomas Dahl, Lan Bo Chen, Mika Scheinin, Jaana Suopanki‐Lalowski, Marju Valge, Antti Puhakka, Hannu Mikola, Zsófia Lovró, Axel Meierjohann, Lauri Vuorilehto & Thomas Roth. (2019) Pharmacodynamic and pharmacokinetic profile of SM‐1, a triple‐drug combination to increase total sleep time. Human Psychopharmacology: Clinical and Experimental 34:6.
Crossref
Crossref
Thomas Dahl, Lan Bo Chen, Gary Zammit, Maha Ahmad & Thomas Roth. (2019) Efficacy of SM‐1 in a transient insomnia model. Human Psychopharmacology: Clinical and Experimental 34:6.
Crossref
Crossref
Younggi Choi & Brian K. Raymer. (2019) Sleep modulating agents. Bioorganic & Medicinal Chemistry Letters 29:16, pages 2025-2033.
Crossref
Crossref
David J. Greenblatt, Jerold S. Harmatz & Thomas Roth. (2019) Zolpidem and Gender: Are Women Really At Risk?. Journal of Clinical Psychopharmacology 39:3, pages 189-199.
Crossref
Crossref
Ching-Wen Chu & Chih-Sung Liang. (2019) Low-Dose Aripiprazole-Associated Sleepwalking in a Long-Term Zolpidem Treatment Patient With a Depressive Episode. Journal of Clinical Psychopharmacology 39:2, pages 174-175.
Crossref
Crossref
Dimce Zafirov, Jasmina Trojacanec, Dragica Zendelovska, Nikola Kolovcevski & Bojan Labachevski. (2019) Comparative single-dose bioavailability study of two 10 mg Zolpidem tablet formulations in healthy volunteers. Macedonian Pharmaceutical Bulletin 65:01, pages 11-17.
Crossref
Crossref
Andrea Lawson, Roohie Parmar & Eileen P. Sloan. 2019. Perinatal Psychopharmacology. Perinatal Psychopharmacology
341
376
.
Shasha Zhang, Xiaojuan Liu, Wei Yuan, Wei Zheng, Hongkun Li, Chenghui Li, Yufang Sun, Yong Wang, Yonggang Yang, Yahong Li & Wei Liu. (2018) New aryl substituted pyridylimidazo[1,2-a]pyridine-BODIPY conjugates: Emission color tuning from green to NIR. Dyes and Pigments 159, pages 406-418.
Crossref
Crossref
Ji-Yeong Byeon, Young-Hoon Kim, Se-Hyung Kim, Choong-Min Lee, Eui-Hyun Jung, Won-Ki Chae, Choon-Gon Jang, Seok-Yong Lee & Yun Jeong Lee. (2018) The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem. Archives of Pharmacal Research 41:9, pages 931-936.
Crossref
Crossref
Maja Jazvinšćak Jembrek, Vedrana Radovanović, Josipa Vlainić, Lidija Vuković & Nikolina Hanžić. (2018) Neuroprotective effect of zolpidem against glutamate-induced toxicity is mediated via the PI3K/Akt pathway and inhibited by PK11195. Toxicology 406-407, pages 58-69.
Crossref
Crossref
Ji-Yeong Byeon, Young-Hoon Kim, Se-Hyung Kim, Choong-Min Lee, Eui-Hyun Jung, Won-Ki Chae, Choon-Gon Jang, Seok-Yong Lee & Yun Jeong Lee. (2018) Effects of genetic polymorphisms of CYP2C19 on the pharmacokinetics of zolpidem. Archives of Pharmacal Research 41:8, pages 861-866.
Crossref
Crossref
Rohini N. Udavant, Ashok R. Yadav & Sandip S. Shinde. (2018)
One-Pot Sequential Bromination and Fluorination to Access 3-Fluoroimidazo[1,2-
a
]pyridines from Arylketones
. European Journal of Organic Chemistry 2018:26, pages 3432-3436.
Crossref
Crossref
Shasha Zhang, Wei Yuan, Yaru Qin, Jin Zhang, Ning Lu, Wei Liu, Hongkun Li, Yong Wang & Yahong Li. (2018) Bidentate BODIPY-appended 2-pyridylimidazo[1,2-a]pyridine ligand and fabrication of luminescent transition metal complexes. Polyhedron 148, pages 22-31.
Crossref
Crossref
Stephen G Brickley, Nicholas P Franks & William Wisden. (2018) Modulation of GABA A receptor function and sleep. Current Opinion in Physiology 2, pages 51-57.
Crossref
Crossref
David J. Greenblatt, Jerold S. Harmatz & Richard I. Shader. (2018) Update on Psychotropic Drug Prescribing in the United States. Journal of Clinical Psychopharmacology 38:1, pages 1-4.
Crossref
Crossref
Xiao Yu, Nicholas P. Franks & William Wisden. (2018) Sleep and Sedative States Induced by Targeting the Histamine and Noradrenergic Systems. Frontiers in Neural Circuits 12.
Crossref
Crossref
Min-Kyun Oh, Kyung Jae Yoon, Yong-Taek Lee, Seoung Wan Chae, Hye Young Choi, Hee Suk Shin, Yun Hee Park, Se-Woong Chun & Young Sook Park. (2017) Effect of zolpidem on functional recovery in a rat model of ischemic stroke. Journal of International Medical Research 46:1, pages 249-257.
Crossref
Crossref
Hui-Ting Cheng, Fang-Ju Lin, Steven R. Erickson, Jin-Liern Hong & Chung-Hsuen Wu. (2017) The Association Between the Use of Zolpidem and the Risk of Alzheimer's Disease Among Older People. Journal of the American Geriatrics Society 65:11, pages 2488-2495.
Crossref
Crossref
Yuxiao Wu, Wei Yuan, Heyi Ji, Yaru Qin, Jin Zhang, Hongkun Li, Yahong Li, Yong Wang, Yufang Sun & Wei Liu. (2017) New fluorescent imidazo[1,2- a ]pyridine-BODIPY chromophores: Experimental and theoretical approaches, and cell imaging exploration. Dyes and Pigments 142, pages 330-339.
Crossref
Crossref
Dirk K. Wolter. (2017) Suchtpotenzial und andere Risiken von Benzodiazepinen und Z-Drugs im Alter. SUCHT 63:2, pages 81-97.
Crossref
Crossref
Jaime M. Monti, David Warren Spence, Kenneth Buttoo & Seithikurippu R. Pandi-Perumal. (2017) Zolpidem’s use for insomnia. Asian Journal of Psychiatry 25, pages 79-90.
Crossref
Crossref
Jaime M. Monti. 2017. Sleep Disorders Medicine. Sleep Disorders Medicine
1187
1207
.
W. Wisden, X. Yu & N. P. Franks. 2019. Sleep-Wake Neurobiology and Pharmacology. Sleep-Wake Neurobiology and Pharmacology
279
304
.
Lise Eliot & Sarah S. Richardson. (2016) Sex in Context: Limitations of Animal Studies for Addressing Human Sex/Gender Neurobehavioral Health Disparities. The Journal of Neuroscience 36:47, pages 11823-11830.
Crossref
Crossref
David S. Uygun, Zhiwen Ye, Anna Y. Zecharia, Edward C. Harding, Xiao Yu, Raquel Yustos, Alexei L. Vyssotski, Stephen G. Brickley, Nicholas P. Franks & William Wisden. (2016) Bottom-Up versus Top-Down Induction of Sleep by Zolpidem Acting on Histaminergic and Neocortex Neurons. The Journal of Neuroscience 36:44, pages 11171-11184.
Crossref
Crossref
Chia-Ling Lin, Chi-Hsiang Chung, Yu-Hsia Tsai & Wu-Chien Chien. (2016) Association between sleep disorders and injury: a nationwide population-based retrospective cohort study. Injury Prevention 22:5, pages 342-346.
Crossref
Crossref
David L. Lipschitz, Jonathan A. Olin & Yoshio Nakamura. (2016) A randomized controlled pilot study of a mind-body intervention compared with treatment as usual in the management of insomnia among active duty military personnel. European Journal of Integrative Medicine 8:5, pages 769-780.
Crossref
Crossref
S. M. Park, J. Ryu, D. R. Lee, D. Shin, J. M. Yun & J. Lee. (2016) Zolpidem use and risk of fractures: a systematic review and meta-analysis. Osteoporosis International 27:10, pages 2935-2944.
Crossref
Crossref
Yusuke Furukawa, Kentaro Tanemura, Katsuhide Igarashi, Maky Ideta-Otsuka, Ken-Ichi Aisaki, Satoshi Kitajima, Masanobu Kitagawa & Jun Kanno. (2016) Learning and Memory Deficits in Male Adult Mice Treated with a Benzodiazepine Sleep-Inducing Drug during the Juvenile Period. Frontiers in Neuroscience 10.
Crossref
Crossref
Serkan Güneş & Mehmet Akif Camkurt. (2016) Sleep-Related Eating Disorder Associated With Risperidone. Journal of Clinical Psychopharmacology 36:3, pages 286-288.
Crossref
Crossref
Thomas M. Polasek, Vidya Perera & Yolande Lucire. (2016) Serious adverse drug reactions to zolpidem: does impaired metabolic clearance and concurrent SSRI/SNRI use increase risk?. Journal of Pharmacy Practice and Research 46:2, pages 139-142.
Crossref
Crossref
Gregory S Parks, Deepti R Warrier, Lars Dittrich, Michael D Schwartz, Jeremiah B Palmerston, Thomas C Neylan, Stephen R Morairty & Thomas S Kilduff. (2015) The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems. Neuropsychopharmacology 41:4, pages 1144-1155.
Crossref
Crossref
Damian E. Yerien, Sergio Bonesi & Al Postigo. (2016) Fluorination methods in drug discovery. Organic & Biomolecular Chemistry 14:36, pages 8398-8427.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
65
76
.
Laura H. Jacobson, Sui Chen, Sanjida Mir & Daniel Hoyer. 2017. Behavioral Neuroscience of Orexin/Hypocretin. Behavioral Neuroscience of Orexin/Hypocretin
105
136
.
Gregory Asnis, Manju Thomas & Margaret Henderson. (2015) Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians. International Journal of Molecular Sciences 17:1, pages 50.
Crossref
Crossref
Ping Liu, Yongyuan Gao, Weijin Gu, Ziyan Shen & Peipei Sun. (2015)
Regioselective Fluorination of Imidazo[1,2-
a
]pyridines with Selectfluor in Aqueous Condition
. The Journal of Organic Chemistry 80:22, pages 11559-11565.
Crossref
Crossref
Yuhei Nishimura, Shiko Okabe, Shota Sasagawa, Soichiro Murakami, Yoshifumi Ashikawa, Mizuki Yuge, Koki Kawaguchi, Reiko Kawase & Toshio Tanaka. (2015) Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers. Frontiers in Pharmacology 6.
Crossref
Crossref
Chia-Ling Lin, Mei-Chang Yeh, Tomor Harnod, Cheng-Li Lin & Chia-Hung Kao. (2015) Risk of Type 2 Diabetes in Patients With Nonapnea Sleep Disorders in Using Different Types of Hypnotics. Medicine 94:38, pages e1621.
Crossref
Crossref
Kuan-Fu Liao, Cheng-Li Lin, Shih-Wei Lai & Wen-Chi Chen. (2015) Zolpidem Use Associated With Increased Risk of Pyogenic Liver Abscess. Medicine 94:32, pages e1302.
Crossref
Crossref
Michele L. Okun, Rebecca Ebert & Bandana Saini. (2015) A review of sleep-promoting medications used in pregnancy. American Journal of Obstetrics and Gynecology 212:4, pages 428-441.
Crossref
Crossref
Suengmok Cho & Makoto Shimizu. 2015. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease
141
151
.
Fabiana d’ Aniello, Benjamin Santos & Antonio Guglietta. 2015. Drug Treatment of Sleep Disorders. Drug Treatment of Sleep Disorders
121
145
.
Gloria Martin & Antonio Guglietta. 2015. Drug Treatment of Sleep Disorders. Drug Treatment of Sleep Disorders
85
107
.
James MacFarlane, Charles M. Morin & Jacques Montplaisir. (2014) Hypnotics in Insomnia: The Experience of Zolpidem. Clinical Therapeutics 36:11, pages 1676-1701.
Crossref
Crossref
Junshui Ma, Vladimir Svetnik, Ellen Snyder, Christopher Lines, Thomas Roth & W. Joseph Herring. (2014) Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects. Sleep 37:10, pages 1609-1619.
Crossref
Crossref
David J. Greenblatt, Jerold S. Harmatz, Nikhilesh N. Singh, Frank Steinberg, Thomas Roth, Stephen C. Harris & Ram P. Kapil. (2014) Pharmacokinetics of Zolpidem from Sublingual Zolpidem Tartrate Tablets In Healthy Elderly Versus Non-Elderly Subjects. Drugs & Aging 31:10, pages 731-736.
Crossref
Crossref
Evan D. Chinoy, Danielle J. Frey, Daniel N. Kaslovsky, Francois G. Meyer & Kenneth P. WrightJr.Jr.. (2014) Age-related changes in slow wave activity rise time and NREM sleep EEG with and without zolpidem in healthy young and older adults. Sleep Medicine 15:9, pages 1037-1045.
Crossref
Crossref
Philip Brenner, Kristina Alexanderson, Charlotte Björkenstam, Jan Hillert, Jussi Jokinen, Ellenor Mittendorfer-Rutz & Petter Tinghög. (2014) Psychiatric Diagnoses, Medication and Risk for Disability Pension in Multiple Sclerosis Patients; a Population-Based Register Study. PLoS ONE 9:8, pages e104165.
Crossref
Crossref
Brittany T. Wright, Catherine F. Gluszek & Scott A. Heldt. (2014) The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam. Psychopharmacology 231:15, pages 2967-2979.
Crossref
Crossref
Lucy Horoszok, Thais Baleeiro, Fabiana D'Aniello, Savion Gropper, Benjamin Santos, Antonio Guglietta & Thomas Roth. (2014) A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjects. Human Psychopharmacology: Clinical and Experimental 29:3, pages 266-273.
Crossref
Crossref
David J. Greenblatt. (2014) Sleep-promoting medications: Weighing the hazards of use versus non-use. Clinical Pharmacology in Drug Development 3:3, pages 167-169.
Crossref
Crossref
Annemiek Vermeeren, Eric F.P.M. Vuurman, Tim R.M. Leufkens, Cees J. Van Leeuwen, Anita C.M. Van Oers, Eugene Laska, Salvador Rico, Frank Steinberg & Thomas Roth. (2014) Residual Effects of Low-Dose Sublingual Zolpidem on Highway Driving Performance the Morning after Middle-of-the-Night Use. Sleep 37:3, pages 489-496.
Crossref
Crossref
William Vaughn McCallJaime M MontiSeithikurippu R Pandi-Perumal. 2014. Advances in the Management of Primary and Secondary Insomnia. Advances in the Management of Primary and Secondary Insomnia
92
103
.
David J. Greenblatt, Jerold S. Harmatz, Nikhilesh N. Singh, Frank Steinberg, Thomas Roth, Margaret L. Moline, Stephen C. Harris & Ram P. Kapil. (2014) Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration. The Journal of Clinical Pharmacology 54:3, pages 282-290.
Crossref
Crossref
Wael M. El-Sayed, Warda A. Hussin, Yasair S. Al-Faiyz & Mohamed A. Ismail. (2013) The position of imidazopyridine and metabolic activation are pivotal factors in the antimutagenic activity of novel imidazo[1,2-a]pyridine derivatives. European Journal of Pharmacology 715:1-3, pages 212-218.
Crossref
Crossref
David J. Greenblatt, Jerold S. Harmatz, Nikhilesh N. Singh, Thomas Roth, Stephen C. Harris & Ram P. Kapil. (2013) Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets. The Journal of Clinical Pharmacology, pages n/a-n/a.
Crossref
Crossref
Susanne Rösner, Michael Soyka, Göran Hajak, Renate Wehrle & Christian Englbrecht. (2013) Zolpidem for insomnia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Shiu-Dong Chung, Ching-Chun Lin, Li-Hsuan Wang, Herng-Ching Lin & Jiunn-Horng Kang. (2013) Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study. PLoS ONE 8:6, pages e67459.
Crossref
Crossref
Naren Gunja. (2013) The Clinical and Forensic Toxicology of Z-drugs. Journal of Medical Toxicology 9:2, pages 155-162.
Crossref
Crossref
David J. Greenblatt, Jerold S. Harmatz, Thomas Roth, Nikhilesh N. Singh, Margaret L. Moline, Stephen C. Harris & Ram P. Kapil. (2013) Comparison of Pharmacokinetic Profiles of Zolpidem Buffered Sublingual Tablet and Zolpidem Oral Immediate-Release Tablet: Results from a Single-Center, Single-Dose, Randomized, Open-Label Crossover Study in Healthy Adults. Clinical Therapeutics 35:5, pages 604-611.
Crossref
Crossref
Horst J. Koch & Christine Gehring. (2015) Hier wurde der Entzug zum Drahtseilakt. MMW - Fortschritte der Medizin 155:8, pages 66-68.
Crossref
Crossref
Emilie Clay, Bruno Falissard, Nicholas Moore & Mondher Toumi. (2012) Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries. European Journal of Clinical Pharmacology 69:4, pages 1-10.
Crossref
Crossref
Jaime M. Monti & Daniel Monti. 2010. Encyclopedia of Psychopharmacology. Encyclopedia of Psychopharmacology
1
5
.